MIPS Home MIPS General Information MIPS Grants MIPS Courses MIPS Research MIPS Software MIPS Web Tools MIPS Sitemap
About MIPS MIPS News Faculty & Staff Recent Pubs Directions Facilities Events & Meetings Employment Associated Depts Useful Links
Grant News CCNE-TR CVIS ICMIC ICBP NTROI SMIS
BIOE222 Pharmacokinetics Stats & Data Analysis
BIOE222A F2009 BIOE222B W2009 BIOE222A F2008 BIOE222B W2008 BIOE222A F2007 BIOE222B W2007 BIOE222 F2006 BIOE222 F2005 BIOE222 F2004
Biswal Lab Blankenberg Lab Cheng Lab Contag Lab Felsher Lab Gambhir Lab Graves Lab Guccione Lab Levin Lab Lin Lab McConnell Moseley Lab Paik Lab Plevritis Lab Ramasamy Lab Rao Lab Rutt Lab Schnitzer Lab Vasanawala Lab Willmann Lab Wu Lab Xing Lab
NCIL MRSRL
AMIDE
NucMed Mediabook PET Brain Atlas PET-FDG Whole Body Atlas




CCNE Home

Nanobiotechnology Seminar

Annual Symposium

CCNE News

Faculty

Postdocs
Graduate Students

Scientific Papers

Corporate Collaboration

Private Foundations

Projects

Core Resources

Pilot Projects

Leadership & Organization

Environment

Links

Employment Opportunities


Center for Cancer Nanotechnology Excellence Focused on Therapy Response

2009 Annual CCNE-TR Symposium

Anna Wu, Ph.D.

Anna Wu, Ph.D.
Professor, Molecular & Medical Pharmacology
Associate Director, Crump Institute for Molecular Imaging
University of California, Los Angeles

Anna M. Wu, Ph.D, is Professor and Vice Chair, Department of Molecular and Medical Pharmacology, at the David Geffen School of Medicine at UCLA, in Los Angeles, California. She also holds appointments as Professor in the Department of Pathology and Laboratory Medicine, UCLA, Associate Director of the Crump Institute for Molecular Imaging, and Director of the Cancer Molecular Imaging Program in the Jonsson Comprehensive Cancer Center at UCLA. Dr. Wu received her A.B. degree in Biochemical Sciences from Harvard University, and a Ph.D. from Yale University in Molecular Biophysics and Biochemistry. Postdoctoral studies were carried out at Yale University and at the University of California, San Francisco. Dr. Wu's research interests include engineered proteins (including antibodies) for targeting and imaging applications in cancer, including the use of SPECT, PET, optical and multimodality approaches. Dr. Wu recently co-founded ImaginAb, focused on engineered antibodies for diagnostic imaging.

[ Back ]
crumpnews events